Literature DB >> 19070990

Autism, ADHD, mental retardation and behavior problems in 100 individuals with 22q11 deletion syndrome.

Lena Niklasson1, Peder Rasmussen, Sólveig Oskarsdóttir, Christopher Gillberg.   

Abstract

This study assessed the prevalence and type of associated neuropsychiatric problems in children and adults with 22q11 deletion syndrome. One-hundred consecutively referred individuals with 22q11 deletion syndrome were given in-depth neuropsychiatric assessments and questionnaires screens. Autism spectrum disorders (ASDs) and/or attention deficit/hyperactivity disorder (ADHD) were diagnosed in 44 cases. ASD was diagnosed in 23 cases of whom only 5 had autistic disorder. ADHD was diagnosed in 30 individuals. In nine of these cases with ASD or ADHD there was a combination of these diagnoses. Mental retardation (MR) with or without ASD/ADHD was diagnosed in 51 individuals. ASD, ADHD, and/or MR were present in 67 cases. Females had higher IQ than males. The results of this study showed that the vast majority of all individuals with 22q11 deletion syndrome have behavior and/or learning problems and more than 40% meet criteria for either ASD, ADHD or both. Neuropsychiatric and neuropsychological evaluations are indicated as parts of the routine clinical assessment of individuals with 22q11 deletion syndrome.

Entities:  

Mesh:

Year:  2008        PMID: 19070990     DOI: 10.1016/j.ridd.2008.10.007

Source DB:  PubMed          Journal:  Res Dev Disabil        ISSN: 0891-4222


  71 in total

Review 1.  Genomic copy number variation in disorders of cognitive development.

Authors:  Eric M Morrow
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-11       Impact factor: 8.829

2.  Working Memory Impairments in Chromosome 22q11.2 Deletion Syndrome: The Roles of Anxiety and Stress Physiology.

Authors:  Ashley F P Sanders; Diana A Hobbs; David D Stephenson; Robert D Laird; Elliott A Beaton
Journal:  J Autism Dev Disord       Date:  2017-04

Review 3.  The 22q11.2 deletion syndrome as a window into complex neuropsychiatric disorders over the lifespan.

Authors:  Rachel K Jonas; Caroline A Montojo; Carrie E Bearden
Journal:  Biol Psychiatry       Date:  2013-08-28       Impact factor: 13.382

Review 4.  Integrative mechanisms of oriented neuronal migration in the developing brain.

Authors:  Irina Evsyukova; Charlotte Plestant; E S Anton
Journal:  Annu Rev Cell Dev Biol       Date:  2013-08-07       Impact factor: 13.827

5.  Cxcr4 regulation of interneuron migration is disrupted in 22q11.2 deletion syndrome.

Authors:  Daniel W Meechan; Eric S Tucker; Thomas M Maynard; Anthony-Samuel LaMantia
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-22       Impact factor: 11.205

6.  Cognitive ability is associated with altered medial frontal cortical circuits in the LgDel mouse model of 22q11.2DS.

Authors:  D W Meechan; H L H Rutz; M S Fralish; T M Maynard; L A Rothblat; A-S LaMantia
Journal:  Cereb Cortex       Date:  2013-11-11       Impact factor: 5.357

7.  Social impairments in chromosome 22q11.2 deletion syndrome (22q11.2DS): autism spectrum disorder or a different endophenotype?

Authors:  Kathleen Angkustsiri; Beth Goodlin-Jones; Lesley Deprey; Khyati Brahmbhatt; Susan Harris; Tony J Simon
Journal:  J Autism Dev Disord       Date:  2014-04

Review 8.  Evolution in health and medicine Sackler colloquium: Comparative genomics of autism and schizophrenia.

Authors:  Bernard Crespi; Philip Stead; Michael Elliot
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-01       Impact factor: 11.205

9.  Psychiatric disorders and autism in young children with 22q11.2 deletion syndrome compared to children with idiopathic autism.

Authors:  Yaffa Serur; Dafna Sofrin Frumer; Keren Daon; Dolly Sobol-Havia; Ronnie Weinberger; Cory Shulman; Doron Gothelf
Journal:  Eur Psychiatry       Date:  2018-11-16       Impact factor: 5.361

Review 10.  New discoveries in schizophrenia genetics reveal neurobiological pathways: A review of recent findings.

Authors:  Alex V Kotlar; Kristina B Mercer; Michael E Zwick; Jennifer G Mulle
Journal:  Eur J Med Genet       Date:  2015-10-19       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.